A Possible Guide as a Tool to Complementary Effects of New Coronavirus

At the end of 2019, Sars-CoV-2 was identified and has since spread in the world. Coronavirus is commonly caused by the upper respiratory tract and severe acute respiratory syndrome in humans. Due to the novel nature of the virus and high mortality among high-risk people, today health care providers...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Afsaneh Sadremomtaz, Javad Hashemi, Adeleh Sahebnasagh, Seyed Mohammad Nabavi, Zayana M.Al-Dahmani, Shayesteh Gheibi, Bita Shahrami, Reza Mosaed, Peyman Arfa, Soheil Roshanzamiri, Mojtaba Mojtahedzadeh
Formato:	article
Lenguaje:	EN
Publicado:	Tehran University of Medical Sciences 2021
Materias:	Sars-CoV-2 Drugs adjuvant therapies Anesthesiology RD78.3-87.3 Medical emergencies. Critical care. Intensive care. First aid RC86-88.9
Acceso en línea:	https://doaj.org/article/64f1d131ed344f4884542650026be316
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:64f1d131ed344f4884542650026be316
record_format	dspace
spelling	oai:doaj.org-article:64f1d131ed344f4884542650026be3162021-11-20T04:39:37ZA Possible Guide as a Tool to Complementary Effects of New Coronavirus10.18502/aacc.v7i4.76332423-5849https://doaj.org/article/64f1d131ed344f4884542650026be3162021-10-01T00:00:00Zhttps://aacc.tums.ac.ir/index.php/aacc/article/view/382https://doaj.org/toc/2423-5849 At the end of 2019, Sars-CoV-2 was identified and has since spread in the world. Coronavirus is commonly caused by the upper respiratory tract and severe acute respiratory syndrome in humans. Due to the novel nature of the virus and high mortality among high-risk people, today health care providers used several medications with different mechanisms to overcome this virus. The course of COVID-19 represents three stages that have different symptoms and used different drugs depends on each stage. Ultimately the minority of patients progress to stage III with high mortality. The aim of this study is a comprehensive review of COVID-19 adjuvant therapies. We explained the current study on the use of Glucocorticoids, Interferon, Vitamin C, Tocilizumab, Anakinra, Pentoxifylline, IVIG, Allopurinol, Ivermectin, and Selenium in sepsis, pneumonia, and ARDS and we suggested a new protocol for prescribing each medication currently used in COVID-19 Outbreak. At the end of 2019, Sars-CoV-2 was identified and has since spread in the world. Coronavirus is commonly caused by the upper respiratory tract and severe acute respiratory syndrome in humans. Due to the novel nature of the virus and high mortality among high-risk people, today health care providers used several medications with different mechanisms to overcome this virus. The course of COVID-19 represents three stages that have different symptoms and used different drugs depends on each stage. Ultimately the minority of patients progress to stage III with high mortality. The aim of this study is a comprehensive review of COVID-19 adjuvant therapies. We explained the current study on the use of Glucocorticoids, Interferon, Vitamin C, Tocilizumab, Anakinra, Pentoxifylline, IVIG, Allopurinol, Ivermectin, and Selenium in sepsis, pneumonia, and ARDS and we suggested a new protocol for prescribing each medication currently used in COVID-19 Outbreak. Afsaneh SadremomtazJavad HashemiAdeleh SahebnasaghSeyed Mohammad NabaviZayana M.Al-DahmaniShayesteh GheibiBita ShahramiReza MosaedPeyman ArfaSoheil RoshanzamiriMojtaba MojtahedzadehTehran University of Medical SciencesarticleSars-CoV-2Drugsadjuvant therapiesAnesthesiologyRD78.3-87.3Medical emergencies. Critical care. Intensive care. First aidRC86-88.9ENArchives of Anesthesia and Critical Care, Vol 7, Iss 4 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Sars-CoV-2 Drugs adjuvant therapies Anesthesiology RD78.3-87.3 Medical emergencies. Critical care. Intensive care. First aid RC86-88.9
spellingShingle	Sars-CoV-2 Drugs adjuvant therapies Anesthesiology RD78.3-87.3 Medical emergencies. Critical care. Intensive care. First aid RC86-88.9 Afsaneh Sadremomtaz Javad Hashemi Adeleh Sahebnasagh Seyed Mohammad Nabavi Zayana M.Al-Dahmani Shayesteh Gheibi Bita Shahrami Reza Mosaed Peyman Arfa Soheil Roshanzamiri Mojtaba Mojtahedzadeh A Possible Guide as a Tool to Complementary Effects of New Coronavirus
description	At the end of 2019, Sars-CoV-2 was identified and has since spread in the world. Coronavirus is commonly caused by the upper respiratory tract and severe acute respiratory syndrome in humans. Due to the novel nature of the virus and high mortality among high-risk people, today health care providers used several medications with different mechanisms to overcome this virus. The course of COVID-19 represents three stages that have different symptoms and used different drugs depends on each stage. Ultimately the minority of patients progress to stage III with high mortality. The aim of this study is a comprehensive review of COVID-19 adjuvant therapies. We explained the current study on the use of Glucocorticoids, Interferon, Vitamin C, Tocilizumab, Anakinra, Pentoxifylline, IVIG, Allopurinol, Ivermectin, and Selenium in sepsis, pneumonia, and ARDS and we suggested a new protocol for prescribing each medication currently used in COVID-19 Outbreak. At the end of 2019, Sars-CoV-2 was identified and has since spread in the world. Coronavirus is commonly caused by the upper respiratory tract and severe acute respiratory syndrome in humans. Due to the novel nature of the virus and high mortality among high-risk people, today health care providers used several medications with different mechanisms to overcome this virus. The course of COVID-19 represents three stages that have different symptoms and used different drugs depends on each stage. Ultimately the minority of patients progress to stage III with high mortality. The aim of this study is a comprehensive review of COVID-19 adjuvant therapies. We explained the current study on the use of Glucocorticoids, Interferon, Vitamin C, Tocilizumab, Anakinra, Pentoxifylline, IVIG, Allopurinol, Ivermectin, and Selenium in sepsis, pneumonia, and ARDS and we suggested a new protocol for prescribing each medication currently used in COVID-19 Outbreak.
format	article
author	Afsaneh Sadremomtaz Javad Hashemi Adeleh Sahebnasagh Seyed Mohammad Nabavi Zayana M.Al-Dahmani Shayesteh Gheibi Bita Shahrami Reza Mosaed Peyman Arfa Soheil Roshanzamiri Mojtaba Mojtahedzadeh
author_facet	Afsaneh Sadremomtaz Javad Hashemi Adeleh Sahebnasagh Seyed Mohammad Nabavi Zayana M.Al-Dahmani Shayesteh Gheibi Bita Shahrami Reza Mosaed Peyman Arfa Soheil Roshanzamiri Mojtaba Mojtahedzadeh
author_sort	Afsaneh Sadremomtaz
title	A Possible Guide as a Tool to Complementary Effects of New Coronavirus
title_short	A Possible Guide as a Tool to Complementary Effects of New Coronavirus
title_full	A Possible Guide as a Tool to Complementary Effects of New Coronavirus
title_fullStr	A Possible Guide as a Tool to Complementary Effects of New Coronavirus
title_full_unstemmed	A Possible Guide as a Tool to Complementary Effects of New Coronavirus
title_sort	possible guide as a tool to complementary effects of new coronavirus
publisher	Tehran University of Medical Sciences
publishDate	2021
url	https://doaj.org/article/64f1d131ed344f4884542650026be316
work_keys_str_mv	AT afsanehsadremomtaz apossibleguideasatooltocomplementaryeffectsofnewcoronavirus AT javadhashemi apossibleguideasatooltocomplementaryeffectsofnewcoronavirus AT adelehsahebnasagh apossibleguideasatooltocomplementaryeffectsofnewcoronavirus AT seyedmohammadnabavi apossibleguideasatooltocomplementaryeffectsofnewcoronavirus AT zayanamaldahmani apossibleguideasatooltocomplementaryeffectsofnewcoronavirus AT shayestehgheibi apossibleguideasatooltocomplementaryeffectsofnewcoronavirus AT bitashahrami apossibleguideasatooltocomplementaryeffectsofnewcoronavirus AT rezamosaed apossibleguideasatooltocomplementaryeffectsofnewcoronavirus AT peymanarfa apossibleguideasatooltocomplementaryeffectsofnewcoronavirus AT soheilroshanzamiri apossibleguideasatooltocomplementaryeffectsofnewcoronavirus AT mojtabamojtahedzadeh apossibleguideasatooltocomplementaryeffectsofnewcoronavirus AT afsanehsadremomtaz possibleguideasatooltocomplementaryeffectsofnewcoronavirus AT javadhashemi possibleguideasatooltocomplementaryeffectsofnewcoronavirus AT adelehsahebnasagh possibleguideasatooltocomplementaryeffectsofnewcoronavirus AT seyedmohammadnabavi possibleguideasatooltocomplementaryeffectsofnewcoronavirus AT zayanamaldahmani possibleguideasatooltocomplementaryeffectsofnewcoronavirus AT shayestehgheibi possibleguideasatooltocomplementaryeffectsofnewcoronavirus AT bitashahrami possibleguideasatooltocomplementaryeffectsofnewcoronavirus AT rezamosaed possibleguideasatooltocomplementaryeffectsofnewcoronavirus AT peymanarfa possibleguideasatooltocomplementaryeffectsofnewcoronavirus AT soheilroshanzamiri possibleguideasatooltocomplementaryeffectsofnewcoronavirus AT mojtabamojtahedzadeh possibleguideasatooltocomplementaryeffectsofnewcoronavirus
_version_	1718419778300805120

A Possible Guide as a Tool to Complementary Effects of New Coronavirus

Ejemplares similares